DIADEM
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
DIADEM
Industry:
Therapeutics
Founded:
2012-06-01
Address:
Brescia, Lombardia, Italy
Country:
Italy
Website Url:
http://www.diademdx.com
Status:
Active
Total Funding:
21.64 M USD
Technology used in webpage:
Nginx Energy Group Hosting
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institute on Aging
National Institute on Aging investment in Grant - Diadem
Panakes Partners
Panakes Partners investment in Venture Round - Diadem
CDP Venture Capital
CDP Venture Capital investment in Venture Round - Diadem
European Investment Bank
European Investment Bank investment in Debt Financing - Diadem
Official Site Inspections
http://www.diademdx.com Semrush global rank: 5.04 M Semrush visits lastest month: 1.65 K
- Host name: srv4.host-my-site1.co.uk
- IP address: 185.211.23.35
- Location: Ballyclare United Kingdom
- Latitude: 54.7682
- Longitude: -6.0186
- Timezone: Europe/London
- Postal: BT39
More informations about "Diadem"
About - Diadem DX
Our Mission. is to enable prediction, monitoring, diagnosis & successful drug development for Alzheimer’s disease. Diadem is determined to solve one of the biggest problems in …See details»
Team - Diadem DX
VP Operations & Development. Simona is VP Operations & Development and an experienced manager with profound knowledge of life science sector. In 2009 she co-founded the company …See details»
DIADEM SpA - LinkedIn
Ahead of AAIC, our CEO, Michael Rasche, had a lunch meeting yesterday with Prof. Dr. Konrad Beyreuther and Prof. Dr. Colin Masters, pioneers in Alzheimer's Disease research.Their contributions to ...See details»
Diadem Company Profile 2024: Valuation, Funding
Diadem General Information Description. Developer of a diagnostic platform designed to predict Alzheimer's disease in advance. The company's platform offers predictions, monitoring, diagnosis, and successful drug development for …See details»
Diadem SpA Announces Exclusive U.S. Licensing Agreement with …
Oct 25, 2023 MILAN and SECAUCUS, N.J., Oct. 25, 2023 /PRNewswire/ -- Diadem SpA, (Diadem), a company developing one of the first blood-based tests for the early and accurate …See details»
Diadem - Crunchbase Company Profile & Funding
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.See details»
Diadem S.p.A. (Diadem Dx) - Life-Sciences-Europe.com
Mar 28, 2022 https://www.diademdx.com Diadem was founded as a spin-out of the University of Brescia (Italy). The company is developing the first blood-based prognostic test for the early …See details»
Diadem Builds Out Executive Team As It Prepares for …
Nov 21, 2022 —Diadem to Participate in the 15 th Clinical Trials on Alzheimer's Disease (CTAD) Conference—. MILAN, Nov. 21, 2022 /PRNewswire/ -- Diadem SpA, (or Diadem US, Inc.) a …See details»
Diadem US Inc - Diadem DX
Sam is board-certified neurologist and a seasoned medication and device (including software as medical device) development expert, with more than 20 years of global experience in multiple …See details»
Diadem Dx | Panakès Partners
Diademdx.com Diadem is a clinical stage Italian in-vitro diagnostic start-up founded in 2012 that has developed a novel blood-based test exploiting a proprietary biomarker specific for …See details»
Diadem Announces First Closing of €10 Million Equity Financing …
Mar 28, 2022 /PRNewswire/ -- Diadem SpA, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced the closing...See details»
Diadem SpA Announces Exclusive U.S. Licensing Agreement with …
Oct 25, 2023 /PRNewswire/ -- Diadem SpA, (Diadem), a company developing one of the first blood-based tests for the early and accurate prediction of clinical progression to...See details»
Board of Directors - Diadem DX
Member of the board. She is Founder and Managing Partner of Panakes Partners SGR one of the major Med Tech venture investors in Europe. She brings almost 20 years of experience in …See details»
FDA Grants Breakthrough Device Designation to Diadem's …
SAN FRANCISCO, Jan. 18, 2022 /PRNewswire/ -- Diadem U.S., Inc.,(a subsidiary of Diadem Srl) a company developing the first blood-based test for the early prediction of Alzheimer's disease …See details»
Diadem Company Information - Funding, Investors, and More
Jan 1, 2022 https://diademdx.com. Blood-based test utilizing a unique antibody to target a specific p53 protein shape for medical analysis. GET THE TOP 10 COMPANIES OF THE …See details»
Board of Directors - Diadem DX
Member of the board. Paul has over 30 years of experience in the global life sciences industry, with an executive career focused on Clinical Diagnostics and innovative products to improve …See details»
Diadem - VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»
News - Diadem DX
Mar 7, 2022 Legal Headquarters: Diadem SpA Via Ceresio 7 Milano, Italy. Diadem US, Inc 1117 S.California Avenue Palo Alto , CA94304. Diadem GmbH Faberstrasse 8D 81373 München, …See details»
Diadem Receives CE-IVD Certification to Market Its AlzoSure® …
BRESCIA, Italy, Feb. 28, 2022 /PRNewswire/ -- Diadem Srl today announced CE IVD certification for its AlzoSure ® Predict prognostic blood test for the early prediction of Alzheimer's disease …See details»